This clinical trial evaluates if women prefer to complete cervical cancer screening via an in-clinic pap test or by a human papilloma virus at home self-test, when offered the choice. The study also tests to see whether women go on to complete follow-up care that health care providers recommend. The focus of this trial is on increasing follow up (adherence) to cervical cancer screening and linkage to care through tailored support and patient navigation to local resources in underserved women. Offering patients choices related to screening may be an effective way to increase adherence to cancer screening and care in underserved populations.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05390567.
Locations matching your search criteria
United States
Florida
Gainesville
UF Health Cancer Institute - GainesvilleStatus: Active
Contact: Ramzi G. Salloum
Phone: 352-359-5184
PRIMARY OBJECTIVE:
I. Examine adherence to the cancer screening continuum steps from screening to colposcopy for women who choose self-testing compared to women who choose Pap/human papillomavirus (HPV) testing for each step in the continuum for which the women are eligible.
SECONDARY OBECTIVE:
I. Characterize the health and sociodemographic characteristics of women who choose HPV self-testing, Pap/HPV testing or none.
EXPLORATORY OBJECTIVE:
I. Estimate the number and percentage of women who move on to the next cancer screening step for designing the subsequent larger study.
OUTLINE:
ARM I (C-LEAR TRAINING): Clinicians, navigators, and study staff attend an HPV informational training session, view a video and live demonstration, and participate in focus group role play scenarios to reinforce messaging related to the importance of screening and obtaining recommended follow-up care on study. Clinicians, navigators, and study staff recommend patients to get a pap test and link them to an appointment scheduler to schedule the test, and also send out patient reminders for keeping scheduled appointments.
RECRUITMENT: Patients participate in an educational session with clinicians and navigators and receive educational materials about HPV testing on study. Patients are assigned to 1 of 2 arms. Patients who choose to have HPV self-testing are assigned to Arm II. Patients who choose to have a pap test in clinic are assigned to Arm III.
ARM II (Self-test): Patients receive a follow up text message, telephone call, or email by a clinician or navigator to remind them to complete self-test. Patients undergo self-testing and receive a call or text reminder when test results are available. Patients who test positive schedule a pap test to confirm positive results and receive reminders of upcoming appointment. Patients who test positive schedule a colposcopy and receive a follow up reminder to attend appointment.
ARM III (In-clinic): Patients receive assistance by the clinical navigator to make a screening appointment for an in-clinic pap test. Patients receive a follow up text message, telephone call, or email by a clinical navigator to remind them of their upcoming appointment. Patients undergo pap tests in a clinic and receive a call or text reminder when test results are available. Patients who test positive schedule a colposcopy and receive a follow up reminder to attend appointment.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationUF Health Cancer Institute - Gainesville
Principal InvestigatorRamzi G. Salloum